GIPHARMA can manufacture injectable products requiring either:
Completely Aseptical Manufacturing Process or Terminal Sterilization.

Lyophilization batch size can reach 14000 vials (10 ml. capacity).

GIPHARMA can release batches requiring the following testing:

• Chemical

• Microbiological

• Radiochemical

• Biodistribution

• Acute toxicity